(Q35126727)

English

Development and clinical testing of multivalent vaccines based on a diphtheria–tetanus–acellular pertussis vaccine: difficulties encountered and lessons learned

scientific article published on June 2, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

Development and clinical testing of multivalent vaccines based on a diphtheria-tetanus-acellular pertussis vaccine: difficulties encountered and lessons learned (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Development and clinical testing of multivalent vaccines based on a diphtheria–tetanus–acellular pertussis vaccine: difficulties encountered and lessons learned (English)

1 reference

10.1016/S0264-410X(03)00107-5

https://api.crossref.org/works/10.1016/S0264-410X(03)00107-5

2 January 2024

lessons learned

1 reference

based on heuristic

inferred from title

pertussis vaccine

1 reference

based on heuristic

inferred from title

molecular medicine

1 reference

10.1016/S0264-410X(03)00107-5

https://api.crossref.org/works/10.1016/S0264-410X(03)00107-5

2 January 2024

author name string

Carine Capiau

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jan Poolman

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Bernard Hoet

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Hugues Bogaerts

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Francis Andre

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2 June 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12744858

2 January 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0264410X03001075?httpAccept=text/xml

1 reference

10.1016/S0264-410X(03)00107-5

https://api.crossref.org/works/10.1016/S0264-410X(03)00107-5

2 January 2024

https://api.elsevier.com/content/article/PII:S0264410X03001075?httpAccept=text/plain

1 reference

10.1016/S0264-410X(03)00107-5

https://api.crossref.org/works/10.1016/S0264-410X(03)00107-5

2 January 2024

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

19-20

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2273-2287

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United State: A Comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of anti-vaccine movements on pertussis control: the untold story

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute encephalopathy and chronic neurological damage after pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pertussis in Sweden after the cessation of general immunization in 1979.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Current epidemiology of pertussis in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Acellular pertussis vaccines have arrived

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a three-component acellular pertussis vaccine with whole cell pertussis vaccine in two-month-old children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody responses and reactions to the whole cell pertussis component of a combined diphtheria/tetanus/pertussis vaccine given at school entry.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and reactogenicity of acellular diphtheria/tetanus/pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A 7-year survey of disorders attributed to vaccination in North West Thames region

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The APDT Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of serious adverse reactions to whole cell and acellular pertussis vaccines in South Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Marked decline in pertussis followed reintroduction of pertussis vaccination in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mouse Protection Tests in the Study of Pertussis Vaccine: A Comparative Series Using the Intracerebral Route for Challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity Issues in the Quality Control of the New Acellular Pertussis Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and clinical application of new polyvalent combined paediatric vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The hidden costs of infant vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of lower Hib response in DTPa-based combination vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactogenicity of DTPa-HBV/Hib vaccine administered as a single injection vs DTPa-HBV and Hib vaccines administered simultaneously at separate sites, to infants at 2, 4 and 6 months of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility study of a combined diphtheria-tetanus-acellular pertussis-hepatitis B (DTPa-HBV) vaccine, and comparison of clinical reactions and immune responses with diphtheria-tetanus-acellular pertussis (DTPa) and hepatitis B vaccines applied as m

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules. Multicenter Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of combined Dtpa-IPV vaccine for primary and booster vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900107-5

7 January 2021

based on heuristic

inferred from DOI database lookup

DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose

7

1 reference

10.1016/S0264-410X(03)00107-5

https://api.crossref.org/works/10.1016/S0264-410X(03)00107-5

2 January 2024

Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience

11

1 reference

10.1016/S0264-410X(03)00107-5

https://api.crossref.org/works/10.1016/S0264-410X(03)00107-5

2 January 2024

The epidemiological situation of pertussis in the Federal Republic of Germany

13

1 reference

10.1016/S0264-410X(03)00107-5

https://api.crossref.org/works/10.1016/S0264-410X(03)00107-5

2 January 2024

Cell-mediated immunity after pertussis vaccination and after natural infection

30

1 reference

10.1016/S0264-410X(03)00107-5

https://api.crossref.org/works/10.1016/S0264-410X(03)00107-5

2 January 2024

Identifiers

10.1016/S0264-410X(03)00107-5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35126727&oldid=2042944901"